Varian Medical Systems Invests in Bendit Technologies

March 25, 2021—Varian Medical Systems, Inc. announced a new investment in Bendit Technologies Ltd., a medical device company based in Petach Tikva, Israel, that is developing the Bendit steerable microcatheters for use by interventionalists performing minimally invasive peripheral vascular procedures. The devices can be used to deliver diagnostic, embolic, or therapeutic materials into the vasculature.

Varian is investing in Bendit Technologies’ Series B funding. In addition, a Varian representative will be joining Bendit’s Board of Directors.

Varian advised that Bendit has United States FDA 510(k) clearance and European CE Mark approval for its technology, which provides three-dimensional (3D)–controlled bending and navigation capabilities that enable doctors to deliver treatment quickly and precisely by placing catheters through even tortuous blood vessels that are otherwise difficult to traverse. The Bendit peripheral use microcatheter also enables doctors to navigate into the body through the femoral artery and, potentially, through the radial artery, which can reduce patient risk for certain procedures.

Francis Facchini, MD, who is President of Varian’s Interventional Solutions business, commented in the company’s announcement, “The Bendit catheters’ unique design brings 3D steerability to a new dimension in microcatheter technologies, providing interventional radiologists with control of the catheter tip and tip shape to successfully navigate even the most tortuous anatomy. This optimizes ‘guidewireless’ navigation for delivery of embolic therapies.”

Dr. Facchini continued, “Since launching our Interventional Solutions business last year, Varian has been looking at a wide spectrum of innovative new technologies for advancing the field of interventional medicine. We believe the Bendit steerable microcatheter has the potential to enhance patient safety, reduce procedure time, and produce better outcomes.”